These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16320975)

  • 41. [Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic].
    Jansa P; Ambroz D; Maresová J; Jelínková L; Polácek P; Palecek T; Aschermann M; Linhart A
    Vnitr Lek; 2007 Apr; 53(4):333-7. PubMed ID: 17578162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
    Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children.
    Nakayama T; Shimada H; Takatsuki S; Hoshida H; Ishikita T; Matsuura H; Saji T
    Circ J; 2007 Nov; 71(11):1785-90. PubMed ID: 17965503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.
    Mereles D; Ehlken N; Kreuscher S; Ghofrani S; Hoeper MM; Halank M; Meyer FJ; Karger G; Buss J; Juenger J; Holzapfel N; Opitz C; Winkler J; Herth FF; Wilkens H; Katus HA; Olschewski H; Grünig E
    Circulation; 2006 Oct; 114(14):1482-9. PubMed ID: 16982941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
    Bendayan D; Fink G; Aravot D; Ygla M; Bendov I; Bliden L; Nir A; Kramer MR
    Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome after pulmonary endarterectomy.
    Corsico AG; D'Armini AM; Cerveri I; Klersy C; Ansaldo E; Niniano R; Gatto E; Monterosso C; Morsolini M; Nicolardi S; Tramontin C; Pozzi E; Viganò M
    Am J Respir Crit Care Med; 2008 Aug; 178(4):419-24. PubMed ID: 18556630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
    Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication?
    Patel ND; Williams JA; Nwakanma LU; Waldron MM; Bluemke DA; Conte JV
    Ann Thorac Surg; 2006 Sep; 82(3):879-88; discussion 888. PubMed ID: 16928501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.
    Humbert M; Sanchez O; Fartoukh M; Jagot JL; Le Gall C; Sitbon O; Parent F; Simonneau G
    Eur Respir J; 1999 Jun; 13(6):1351-6. PubMed ID: 10445611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization.
    Wong YY; Ruiter G; Lubberink M; Raijmakers PG; Knaapen P; Marcus JT; Boonstra A; Lammertsma AA; Westerhof N; van der Laarse WJ; Vonk-Noordegraaf A
    Circ Heart Fail; 2011 Nov; 4(6):700-6. PubMed ID: 21900188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of inspiratory muscle training on autonomic activity, endothelial vasodilator function, and N-terminal pro-brain natriuretic peptide levels in chronic heart failure.
    Laoutaris ID; Dritsas A; Brown MD; Manginas A; Kallistratos MS; Chaidaroglou A; Degiannis D; Alivizatos PA; Cokkinos DV
    J Cardiopulm Rehabil Prev; 2008; 28(2):99-106. PubMed ID: 18360185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
    Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of systemic ventricular function quantified by myocardial performance index (Tei) to cardiopulmonary exercise capacity in adults after Mustard procedure for transposition of the great arteries.
    Norozi K; Buchhorn R; Alpers V; Arnhold JO; Schoof S; Zoege M; Geyer S; Wessel A
    Am J Cardiol; 2005 Dec; 96(12):1721-5. PubMed ID: 16360364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
    Badesch DB; Tapson VF; McGoon MD; Brundage BH; Rubin LJ; Wigley FM; Rich S; Barst RJ; Barrett PS; Kral KM; Jöbsis MM; Loyd JE; Murali S; Frost A; Girgis R; Bourge RC; Ralph DD; Elliott CG; Hill NS; Langleben D; Schilz RJ; McLaughlin VV; Robbins IM; Groves BM; Shapiro S; Medsger TA
    Ann Intern Med; 2000 Mar; 132(6):425-34. PubMed ID: 10733441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
    J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.